X-1 (Emergent)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameX-1 (Emergent)
Drug Alias NameTNFR X Anti-IL-6/IL-6R (Trubion Pharmaceuticals/Emergent)TNFR-x-TWEAKRAnti-TNF-based therapeutics (Trubion/Emergent)X-1 (Trubion)TNFR-x-A2 +[6] 
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment
Mechanisms of ActionIL-6 receptor antagonistsTumor necrosis factor inhibitors
TargetsTumor necrosis factorIL-6 receptor
Therapy Area/IndicationsInflammationDiabetic NephropathiesEye Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTrubion Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTrubion Pharmaceuticals IncEmergent Biosolutions Inc
Active IndicationsN/A
Inactive IndicationsInflammationDiabetic NephropathiesEye Diseases

Other Information

ATC CodeN/A
Related LinksN/A